ST.
PAUL, Minn., April 15,
2024 /PRNewswire/ -- Solventum (NYSE: SOLV) announced
today that its Board of Directors appointed Shirley Edwards, former partner, EY, to the
board. Edwards will serve on Solventum's Audit and Talent
committees, effective April 12,
2024.
"We are excited to welcome Shirley to our Board of Directors.
Her extensive expertise in mergers and acquisitions, corporate
governance, performance enhancement, finance and human resources
will serve as a valuable resource as Solventum advances its
specialized growth and market strategies, along with capital
allocation approaches," said Bryan
Hanson, chief executive officer, Solventum.
From 2002 to 2022, Edwards distinguished herself as a partner at
EY, culminating in her role as global client service partner from
2017 to 2022. Her career at EY was marked by significant leadership
and client service roles, including the stewardship of EY's nearly
$4B assurance practice across 20
countries in the Americas, encompassing 10 regions and a team of
over 20,000 professionals. She was instrumental in driving the
strategy for audit, forensics, and financial accounting and
advisory services throughout the Americas. Beyond her professional
achievements, Edwards has contributed her expertise as a board
member and advisor to several esteemed organizations, including the
Girl Scouts of the Nation's Capital, Leadership Greater Washington,
the Pamplin College of Business Advisory Council at Virginia Tech,
National Capital Region Advisory Board for the American Red Cross
and is currently a board member at Appian Corporation and Cumming
Group. She holds a Bachelor of Science in accounting from
Virginia Tech.
"Shirley joins a robust board that brings deep expertise across
healthcare, strategy and finance. We are ready to bring forward
Solventum's mission of enabling better, smarter, safer health care
to improve lives," said Carrie Cox,
chairman of the Board of Directors, Solventum.
Current Solventum board members include:
- Bryan Hanson, chief executive
officer, Solventum
- Carrie S. Cox, former chief
executive officer, Humacyte, Inc.
- Susan D. DeVore, former chief
executive officer, Premier Inc.
- Glenn A. Eisenberg, executive
vice president and chief financial officer, Laboratory Corporation
of America Holdings
- Dr. Bernard A. Harris Jr.,
former NASA astronaut, chief executive officer and managing
partner, Versalius Ventures, Inc.
- Karen J. May, former executive
vice president and chief human resources officer, Mondelez
International, Inc.
- Elizabeth A. Mily, former
executive vice president, strategy & business development,
Bristol-Myers Squibb
- John H. Weiland, former
president and chief operating officer, C.R. Bard, Inc.
- Amy A. Wendell former senior
vice president, strategy and business development and
licensing, Covidien
- Darryl L. Wilson, former vice
president, commercial, GE
- Carlos Albán, former vice chairman and chief commercial
officer, AbbVie, Inc.
For more information on Solventum's Board of Directors, visit
Solventum.com.
About Solventum
At Solventum, we enable better, smarter, safer healthcare to
improve lives. As a new company with a long legacy of creating
breakthrough solutions for our customers' toughest challenges, we
pioneer game-changing innovations at the intersection of health,
material and data science that change patients' lives for the
better — while empowering healthcare professionals to perform at
their best.
See how at Solventum.com.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/solventum-names-shirley-edwards-to-board-of-directors-302116083.html
SOURCE Solventum